| Income Statement |
| Total Revenue | 248.00M |
|
| Revenues (USD) | 248.00M |
| Cost of Revenue | 11.67M |
| Gross Profit | 236.33M |
| Operating Expenses | 470.08M |
| Research and Development Expense | 10.90M |
| Selling, General and Administrative Expense | 202.14M |
| Operating Income | -233.75M |
| Interest Expense | 4.81M |
| Income Tax Expense | -918.00K |
| Net Income | -230.67M |
| Net Income Common Stock | -230.67M |
| Net Income Common Stock (USD) | -230.67M |
| Consolidated Income | -230.67M |
| Earnings per Basic Share | -5.70 |
| Earnings per Basic Share (USD) | -5.70 |
| Earnings per Diluted Share | -5.70 |
| Earning Before Interest & Taxes (EBIT) | -226.78M |
| Earning Before Interest & Taxes (USD) | -226.78M |
| Weighted Average Shares | 40.45M |
| Balance Sheet |
| Cash and Equivalents | 188.70M |
| Cash and Equivalents (USD) | 188.70M |
| Trade and Non-Trade Receivables | 36.57M |
| Current Assets | 256.22M |
| Property, Plant & Equipment Net | 96.54M |
| Total Assets | 1.33B |
| Total Debt | 398.48M |
| Current Liabilities | 214.12M |
| Debt Non-Current | 398.48M |
| Total Liabilities | 637.85M |
| Accumulated Retained Earnings (Deficit) | -390.52M |
| Accumulated Other Comprehensive Income | 3.55M |
| Shareholders Equity | 687.63M |
| Shareholders Equity (USD) | 687.63M |
| Assets Non-Current | 1.07B |
| Total Debt (USD) | 398.48M |
| Deferred Revenue | 22.95M |
| Goodwill and Intangible Assets | 819.16M |
| Liabilities Non-Current | 423.74M |
| Trade and Non-Trade Payables | 37.55M |
| Tax Assets | 127.58M |
| Tax Liabilities | 1.39M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 22.95M |
| Net Cash Flow from Financing | -67.73M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -55.88M |
| Capital Expenditure | -14.98M |
| Issuance (Repayment) of Debt Securities | -67.45M |
| Net Cash Flow from Investing | -14.98M |
| Net Cash Flow from Operations | 27.24M |
| Effect of Exchange Rate Changes on Cash | -402.00K |
| Share Based Compensation | 4.96M |